Found 38 results
Author Title Type [ Year(Asc)]
Filters: Author is Agrón, Elvira  [Clear All Filters]
2020
T. D. Keenan, Agrón, E., Mares, J. A., Clemons, T. E., van Asten, F., Swaroop, A., and Chew, E. Y., “Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.”, Alzheimers Dement, vol. 16, no. 6, pp. 831-842, 2020.
T. D. Keenan, Agrón, E., Mares, J., Clemons, T. E., van Asten, F., Swaroop, A., and Chew, E. Y., “Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.”, Ophthalmology, 2020.
S. Vitale, Agrón, E., Clemons, T. E., Keenan, T. D. L., Domalpally, A., Danis, R. P., and Chew, E. Y., “Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 22.”, JAMA Ophthalmol, 2020.
T. D. L. Keenan, Clemons, T. E., Domalpally, A., Elman, M. J., Havilio, M., Agrón, E., Benyamini, G., and Chew, E. Y., “Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.”, Ophthalmology, 2020.
T. D. Keenan, Vitale, S., Agrón, E., Domalpally, A., Antoszyk, A. N., Elman, M. J., Clemons, T. E., and Chew, E. Y., “Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.”, Ophthalmol Retina, vol. 4, no. 1, pp. 3-12, 2020.
2019
T. D. Keenan, Wiley, H. E., Agrón, E., Aronow, M. E., Christen, W. G., Clemons, T. E., and Chew, E. Y., “The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.”, Ophthalmology, vol. 126, no. 12, pp. 1647-1656, 2019.
A. K. Tisdale, Agrón, E., Sunshine, S. B., Clemons, T. E., Ferris, F. L., and Chew, E. Y., “Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.”, JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
J. J. Yu, Agrón, E., Clemons, T. E., Domalpally, A., van Asten, F., Keenan, T. D., Cukras, C., and Chew, E. Y., “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.”, Ophthalmology, vol. 126, no. 2, pp. 261-273, 2019.
F. van Asten, Chiu, C. - Y., Agrón, E., Clemons, T. E., Ratnapriya, R., Swaroop, A., Klein, M. L., Fan, R., and Chew, E. Y., “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
A. Domalpally, Agrón, E., Pak, J. W., Keenan, T. D., Ferris, F. L., Clemons, T. E., and Chew, E. Y., “Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”, Ophthalmology, vol. 126, no. 12, pp. 1659-1666, 2019.
2018
C. Papudesu, Clemons, T. E., Agrón, E., and Chew, E. Y., “Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.”, Ophthalmology, vol. 125, no. 4, pp. 512-521, 2018.
A. Y. Lee, Butt, T., Chew, E., Agrón, E., Clemons, T. E., Egan, C. A., Lee, C. S., and Tufail, A., “Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.”, Br J Ophthalmol, vol. 102, no. 4, pp. 465-472, 2018.
F. van Asten, Simmons, M., Singhal, A., Keenan, T. D., Ratnapriya, R., Agrón, E., Clemons, T. E., Swaroop, A., Lu, Z., and Chew, E. Y., “A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.”, Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
2016
S. N. Al-Holou, Tucker, W. R., Agrón, E., Clemons, T. E., Sperduto, R. D., Ferris, F. L., and Chew, E. Y., “The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.”, Ophthalmology, vol. 123, no. 4, pp. 916-7, 2016.
S. Vitale, Clemons, T. E., Agrón, E., Ferris, F. L., Domalpally, A., Danis, R. P., and Chew, E. Y., “Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.”, JAMA Ophthalmol, vol. 134, no. 9, pp. 1041-7, 2016.
A. Domalpally, Danis, R., Agrón, E., Blodi, B., Clemons, T., and Chew, E., “Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.”, Ophthalmology, vol. 123, no. 11, pp. 2401-2407, 2016.
2015
T. S. Glaser, Doss, L. E., Shih, G., Nigam, D., Sperduto, R. D., Ferris, F. L., Agrón, E., Clemons, T. E., and Chew, E. Y., “The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.”, Ophthalmology, vol. 122, no. 7, pp. 1471-9, 2015.
S. N. Al-Holou, Tucker, W. R., Agrón, E., Clemons, T. E., Cukras, C., Ferris, F. L., and Chew, E. Y., “The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.”, Ophthalmology, vol. 122, no. 12, pp. 2490-6, 2015.
M. Indaram, Agrón, E., Clemons, T. E., Sperduto, R. D., Wong, W. T., Ferris, F. L., and Chew, E. Y., “Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.”, Ophthalmology, vol. 122, no. 5, pp. 888-96, 2015.
E. Y. Chew, Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., and Bernstein, P. S., “Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.”, JAMA, vol. 314, no. 8, pp. 791-801, 2015.
B. P. Nicholson, Nigam, D., Toy, B., Stetson, P. F., Agrón, E., Jacobs-El, N., Cunningham, D., Cukras, C., Wong, W., Wiley, H., Chew, E., Ferris, F., and Meyerle, C. B., “Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration.”, Retina, vol. 35, no. 1, pp. 58-68, 2015.
J. Flamendorf, Agrón, E., Wong, W. T., Thompson, D., Wiley, H. E., E Doss, L., Al-Holou, S., Ferris, F. L., Chew, E. Y., and Cukras, C., “Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen.”, Ophthalmology, vol. 122, no. 10, pp. 2053-62, 2015.
2014
E. Y. Chew, Klein, M. L., Clemons, T. E., Agrón, E., Ratnapriya, R., Edwards, A. O., Fritsche, L. G., Swaroop, A., and Abecasis, G. R., “No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.”, Ophthalmology, vol. 121, no. 11, pp. 2173-80, 2014.
E. Y. Chew, Clemons, T. E., Sangiovanni, J. Paul, Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., Fish, G. E., Hubbard, G. Baker, Klein, M. L., Chandra, S. R., Blodi, B. A., Domalpally, A., Friberg, T., Wong, W. T., Rosenfeld, P. J., Agrón, E., Toth, C. A., Bernstein, P. S., and Sperduto, R. D., “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
E. Y. Chew, Clemons, T. E., Agrón, E., Sperduto, R. D., Sangiovanni, J. Paul, Davis, M. D., and Ferris, F. L., “Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.”, JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.